Cargando…
2136. In Vitro Activity of Nacubactam (OP0595) Combined with Cefepime against Carbapenem-resistant Enterobacterales Isolated in Japan
BACKGROUND: Nacubactam is a new non-β-lactam diazabicyclooctane β-lactamase inhibitor that inhibits penicillin binding protein 2 (PBP2) of Enterobacterales and acts synergistically as a β-lactam enhancer when combined with β-lactams. Nacubactam is under development for the treatment of serious Gram-...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678573/ http://dx.doi.org/10.1093/ofid/ofad500.1759 |